Grant: Dissemination Events - Priority Announcement: Hepatitis C

While Canadians are now living for decades with HIV thanks to the discovery of antiretrovirals, they are experiencing a host of new complications resulting from the effects of the virus. As a result, understanding coinfections such as HCV has become an increasingly important focus for the HIV research community. Therefore, HCV coinfection will be an important focus of the 2013 Canadian Association for HIV Research (CAHR) Conference. CAHR is the professional organization for HIV and AIDS research in Canada or by Canadians. CAHR includes all researchers and all disciplines of the scientific approaches to HIV and AIDS, for the purpose of its better prevention and treatment and ultimately for its eradication and cure. The annual CAHR Conference is the premier gathering in Canada for those working in the field of HIV, as well as policy makers, persons living with HIV and other individuals committed to ending the pandemic. It provides a platform for assessment of where we are, evaluation of recent scientific developments and lessons learned, and supports participants in charting a course forward. The 2013 CAHR Conference programme will present new scientific knowledge and offer many opportunities for structured dialogue on the major issues facing the global response to HIV. A variety of session types, from abstract-driven presentations to symposia, bridging and plenary sessions, will meet the needs of various participants. Other related activities, including ancillary meetings, exhibitions, and the CAHR New HIV Researcher Workshop which brings together mentors and trainees, will contribute to an exceptional opportunity for professional development and networking. The 2013 CAHR Conference will: include a session on HCV coinfection involving leading researchers and patients; support opportunities for HCV knowledge brokers to exhibit; and offer expanded opportunities for aspiring HCV researchers to attend the CAHR New Investigator Workshop.